Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tyrosinase inhibitor activity of coumarin-resveratrol hybrids.
Fais A, Corda M, Era B, Fadda MB, Matos MJ, Quezada E, Santana L, Picciau C, Podda G, Delogu G. Fais A, et al. Among authors: matos mj. Molecules. 2009 Jul 13;14(7):2514-20. doi: 10.3390/molecules14072514. Molecules. 2009. PMID: 19633620 Free PMC article.
New halogenated phenylcoumarins as tyrosinase inhibitors.
Matos MJ, Santana L, Uriarte E, Delogu G, Corda M, Fadda MB, Era B, Fais A. Matos MJ, et al. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3342-5. doi: 10.1016/j.bmcl.2011.04.012. Epub 2011 Apr 9. Bioorg Med Chem Lett. 2011. PMID: 21514152
Hydroxycoumarins as selective MAO-B inhibitors.
Serra S, Ferino G, Matos MJ, Vázquez-Rodríguez S, Delogu G, Viña D, Cadoni E, Santana L, Uriarte E. Serra S, et al. Among authors: matos mj. Bioorg Med Chem Lett. 2012 Jan 1;22(1):258-61. doi: 10.1016/j.bmcl.2011.11.020. Epub 2011 Nov 11. Bioorg Med Chem Lett. 2012. PMID: 22137786
Tyrosine-like condensed derivatives as tyrosinase inhibitors.
Matos MJ, Santana L, Uriarte E, Serra S, Corda M, Fadda MB, Era B, Fais A. Matos MJ, et al. J Pharm Pharmacol. 2012 May;64(5):742-6. doi: 10.1111/j.2042-7158.2012.01467.x. Epub 2012 Feb 21. J Pharm Pharmacol. 2012. PMID: 22471371
New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies.
Pintus F, Matos MJ, Vilar S, Hripcsak G, Varela C, Uriarte E, Santana L, Borges F, Medda R, Di Petrillo A, Era B, Fais A. Pintus F, et al. Among authors: matos mj. Bioorg Med Chem. 2017 Mar 1;25(5):1687-1695. doi: 10.1016/j.bmc.2017.01.037. Epub 2017 Jan 31. Bioorg Med Chem. 2017. PMID: 28189394
174 results